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Abstract  
AIM: The aim of this publication is to present a case of CMV infection during pregnancy, with 
clinical manifestations of the development of microcephaly and simultaneous dilatation of the 3rd 
and 4th brain ventricle at 23 weeks gestation. This article discusses the role of ultrasound 
screening in the second trimester of pregnancy. 
CASE PRESENTATION: We present the case of a 25-year-old woman with the initials S.K. in her 
second pregnancy that came to our antenatal Consulting Centre. The first screening for blood 
count, blood group, biochemistry and serology showed results within the reference range. The 
patient came for a second comprehensive biochemical screening at 17 – 18 weeks gestation. The 
results showed the low genetic risk of congenital anomalies. Fetal morphology of the fetus was 
normal. S.K. came again for consultation at 22 weeks gestation in connection with the admittance 
of her first 3-year-old child to the hospital because of pneumonia. Serological tests of the child had 
shown elevated CMV titer - specific IgM. Then we made new serological tests of the patient and the 
results have shown that the patient was most likely infected by CMV primarily in the first trimester of 
pregnancy. After consulting about the risk of transmission of CMV to the fetus, the woman chose 
monthly ultrasound scans and refused amniocentesis. At 36 weeks gestation, in addition to the 
microcephaly already established, enlargement of the IV brain ventricle at the expense of 
underdevelopment of the cerebellum was noticed. Also, 2nd to 3rd stage of placenta maturity and 
low quantity of amniotic fluid was established. A male fetus of weight 2,890 g and height 50 cm was 
delivered.   The fetus was with skin petechiae and hepatosplenomegaly. Neurological examination 
showed no abnormalities. 
CONCLUSIONS: In the described case the time interval between infection and ultrasonic 
manifestations is more than 17 weeks. The long interval between infection and occurrence of 
ultrasound markers can be a good prediction sign, as it may reflect less aggressive viral infection 
than present in cases where similar ultrasound findings were obtained shortly after infection of the 
mother. 
 
Introduction 
 
The cytomegalovirus infection is caused by a 
DNA virus of the viral family known as herpes viruses. 
Presently, CMV can be encountered in every fourth 
woman in childbirth age [1]. Once in the body, the 
virus remains for a lifetime. Usually, the 
cytomegalovirus “sleeps” in the body and does not 
cause any damages [2]. However, when the immunity 
drops, in cases of frequent colds, stress situations and 
pregnancy, the virus becomes active [3]. It is 
important to note that infecting the fetus or the 
newborn infant can happen only with active virus 
infection. During pregnancy, the virus attacks the 
nervous system of the fetus which is connected with 
early miscarriages or with the development of a 
number of defects in the newborn infants, whereas 
20-30% of them die [4]. 
The low pathogenicity of the virus in the adult 
human body is sharply contrasting with the impact on 
the fetus which can cause serious damages. The 
harm for the fetus is even more serious when the 
mother has recently had a primary infection and has 
not developed any specific CMV antibodies. The 
clinical forms of fetal damages are: congenital 
cytomegalic infection acquired perinatal infection and 
acquired postnatal infection [5]. 
The focus of this publication is a case of CMV 
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infection during pregnancy which was clinically 
expressed with the development of microcephaly and 
simultaneous dilatation of the 3
-rd
 and 4
-th
 cerebral 
ventricle in the 23 g.w. This paper presents a 
discussion on the role of the ultrasound testing in the 
second trimester of pregnancy. 
 
Case Presentation 
 
The following is a description of the case of a 
25-year-old woman with the initials S.K. in her second 
pregnancy who came to our antenatal consulting 
centre. 
The first screening for blood count, blood 
group, biochemistry (ALAT, ASAT, creatine, urea, 
blood sugar) showed results within the reference 
range. Hbs Ag, HIV, Wasserman, IgG, IgM 
(toxoplasmosis), IgG, IgM (rubella), IgG, IgM (CMV) 
were negative. 
At that time the woman was at 6 – 7 weeks 
gestation.  Biochemical screening generally is done at 
12 – 13 weeks gestation showed results within the 
reference range (low risk of development of a baby 
with an abnormality, low risk of developing 
preeclampsia in the second half of pregnancy and low 
risk of premature birth). 
The patient came for a second 
comprehensive biochemical screening at 17 – 18 
weeks gestation. The results showed the low genetic 
risk of congenital anomalies. Fetal morphology of the 
fetus was normal. 
S.K. came again for consultation at 22 weeks 
gestation in connection with the admittance of her first 
3-year-old child to the hospital because of pneumonia. 
Serological tests of the child had shown elevated 
CMV titer - specific IgM. 
Then we made new serological tests of the 
patient and the results were as follows: CMV – 
specific IgG – 98; CMV – specific IgM – 2.1. It was 
then understood that the patient was most likely 
infected by CMV primarily in the first trimester of 
pregnancy. After consulting about the risk of 
transmission of CMV to the fetus the woman chose 
monthly ultrasound scans and refused amniocentesis. 
The results of all ultrasound scans were 
normal until that time. At 24 weeks gestation fetal 
brain ultrasound scan showed thalamic calcifications 
bilaterally, hyperechogenic foci in the right side of the 
ventricular wall, asymmetric ventriculomegaly > 10 
mm (Fig. 1). 
Similar changes were imaged at 28 weeks 
gestation and also cerebellar developmental delay 
was noticed. Also, hepatomegaly was found at 
otherwise eutrpophically developing a fetus. 
 
Figure 1: Fetal brain ultrasound scan at 24 weeks gestation 
 
After that patient, S.K. consented to do of 
amniocentesis as changes were already verified by 
ultrasound.  Amniotic fluid analysis detected that the 
fetus was positive for CMV (CMV – specific IgM titer 
was 68), thrombocytopenia – 46 g/l. Levels of fetal 
liver enzymes were normal. Following consultation on 
the possible consequences of CMV infection of the 
fetus, the parents chose to continue with the 
pregnancy. 
In the next ultrasound scanning to follow at 32 
weeks gestation not only cerebellar developmental 
delay was noticed, but also of the head as a whole 
(microcephaly). 
At 36 weeks gestation, in addition to the 
microcephaly already established, enlargement of the 
IV brain ventricle at the expense of underdevelopment 
of the cerebellum was noticed. Also, 2nd to 3rd stage 
of placenta maturity and low quantity of amniotic fluid 
was established (Fig. 2). 
 
Figure 2: Fetal brain ultrasound scan at 36 weeks gestation 
 
The patient was admitted to an obstetrics and 
gynaecology clinic for active monitoring. 
Cardiotocography was done on a daily basis. Upon 
the occurrence of two consecutive non-reactive NST 
and presence of late decelerations, a decision for 
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delivery was taken. Because of the relatively 
immature fetus and low pelvic score a caesarian 
section delivery was done. A male fetus of weight 
2,890 g and height 50 cm was delivered.   The fetus 
was with skin petechiae and hepatosplenomegaly. 
Neurological examination showed no abnormalities. 
Thrombocytopenia was confirmed (Hg 66 g/l). The 
newborn baby was treated with Acyclovir i.v. – 5 mg / 
g / 12 h for 6 weeks (Fig 3). 
 
Figure 3: A male fetus of weight 2,890 g and height 50 cm was 
delivered. The fetus was with skin petechiae and 
hepatosplenomegaly 
 
Presently, the baby is six-month-old, of 
normal neurological status and preserved hearing. 
 
 
Discussion 
 
CMV is the most common congenital viral 
infection and is the leading infectious cause of 
sensory deafness and cerebral mental retardation. 
The estimated risk of vertical transmission in the first 
trimester of pregnancy is 36-45%.  Ten % of infected 
newborn babies are symptomatic at birth and 15 % of 
asymptomatic newborn babies display developmental 
disorders later [6]. 
In the described case the time interval 
between infection and ultrasonic manifestations is 
more than 17 weeks. The long interval between 
infection and occurrence of ultrasound markers can 
be a good prediction sign, as it may reflect less 
aggressive viral infection than present in cases where 
similar ultrasound findings were obtained shortly after 
infection of the mother. 
This case shows that when there is suspicion 
of CMV and patients refuse invasive diagnostics 
(amniocentesis, cordocentesis), monthly ultrasound 
examinations are of exceptional crucial importance. 
According to world statistical data, more than 
80% of the population is infected with the virus. 
Presently, CMV is isolated in every fourth woman of 
childbearing age. Once this virus enters the body, it 
remains there for life [7]. 
Normally, the cytomegalovirus "sleeps" in the 
body and causes no harm. At fall of immunity, 
frequent colds, stress and pregnancy, the virus 
becomes active. It is important to note that infection of 
the fetus or neonate can take place only in an active 
viral infection. Only the test by DNA analysis clearly 
demonstrates active viral infection. 
The most serious complication caused by 
active cytomegalovirus infection during pregnancy is 
an infection of the fetus or neonate. In pregnancy, the 
virus affects the nervous system of the fetus which 
attributes to early miscarriage or development of a 
number of defects in neonate so that 20-30 % of them 
die [8]. 
Unfortunately, in practice congenital 
cytomegalovirus infection is not susceptible to 
treatment and therefore taking of preventive measures 
is required. In pregnant women, it is advisable to 
monitor and control the activity of the virus by 
screening in each trimester [9]. 
In conclusion, the overcoming of the CMV 
infection is possible through the administration of 
antiviral drugs. The purpose of such drugs is to 
suppress viral division (propagation) and to facilitate 
the passage of the virus from active phase to latent 
phase of viral rest, in which the virus is not able to 
infect and harm the body organs. 
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